• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    This Biotechnology Stock Is Trading Lower By 77%, Here Are 62 Stocks Moving In Monday's Mid-Day Session

    8/1/22 12:49:43 PM ET
    $AEMD
    $AJRD
    $AREB
    $BA
    Medical/Dental Instruments
    Health Care
    Military/Government/Technical
    Industrials
    Get the next $AEMD alert in real time by email

    Gainers

    • Ontrak, Inc. (NASDAQ:OTRK) gained 102% to $1.3150. Ontrak is expected to report financial results for the second quarter on Tuesday, August 9, 2022.
    • Virax Biolabs Group Limited (NASDAQ:VRAX) jumped 83.7% to $9.92 after declining 74% on Friday.
    • Mobile Global Esports Inc. (NASDAQ:MGAM) shares gained 56% to $17.47 on post-IPO volatility following Friday's IPO, which was priced at $4 per share.
    • MediaCo Holding Inc. (NASDAQ:MDIA) shares climbed 55% to $3.21. MediaCo Holding 10% owner Soohyung Kim bought a total of 12,899,480 shares at an average price of $2.32.
    • Nanobiotix S.A. (NASDAQ:NBTX) gained 43.1% to $3.32.
    • Aethlon Medical, Inc. (NASDAQ:AEMD) rose 41% to $1.4006 after dropping over 7% on Friday.
    • Liberty TripAdvisor Holdings, Inc. (NASDAQ:LTRPB) gained 37.6% to $22.30 after gaining around 18% on Friday.
    • Celyad Oncology SA (NASDAQ:CYAD) rose 36.2% to $2.3693 after the company said that the FDA has lifted the clinical hold on the CYAD-101-002 (KEYNOTE-B79) Phase 1b trial.
    • GeoVax Labs, Inc. (NASDAQ:GOVX) climbed 32.6% to $3.6100 amid continued strength in monkeypox names. The company also recently announced the publication of a peer-reviewed animal efficacy study of its modified vaccine Ankara vectored vaccine against Sudan ebolavirus.
    • Pagaya Technologies Ltd. (NASDAQ:PGY) surged 28% to $31.82 on continued volatility after the company completed its SPAC merger agreement in June.
    • TherapeuticsMD, Inc. (NASDAQ:TXMD) gained 27% to $7.90 after the company announced it has received a $15 million private investment from Rubric Capital Management.
    • Romeo Power, Inc. (NYSE:RMO) surged 26% to $0.6924 after Nikola announced it will acquire the company in an all-stock transaction for an implied consideration of $0.74 per share.
    • Outset Medical, Inc. (NASDAQ:OM) gained 24.2% to $19.18 after the company announced the resumption of Tablo Hemodialysis System shipments for home use.
    • ToughBuilt Industries, Inc. (NASDAQ:TBLT) gained 22.7% to $8.70 after the company announced it has started to sell 93 of its products on Amazon Italy and Amazon Germany.
    • EVO Payments, Inc. (NASDAQ:EVOP) jumped 22% to $33.36 after Global Payments entered an agreement to acquire the company for $34 per share in cash.
    • Redbox Entertainment Inc. (NASDAQ:RDBX) rose 21.1% to $5.28 after declining around 15% on Friday.
    • Stealth BioTherapeutics Corp (NASDAQ:MITO) gained 19.5% to $0.2889 after the company announced it has entered into a definitive agreement for a going private transaction.
    • Performance Shipping Inc. (NASDAQ:PSHG) jumped 17.4% to $0.3231. Performance Shipping recently entered into a time charter contract with Teekay Chartering Limited, with a gross charter rate of $23,000 per day for a period of roughly 24 months.
    • Celsius Holdings, Inc. (NASDAQ:CELH) gained 16.2% to $103.39 after the company announced a long-term strategic distribution arrangement with PepsiCo, which will also make an investment in Celsius.
    • Volta Inc. (NYSE:VLTA) jumped 15.8% to $2.1312.
    • Rite Aid Corporation (NYSE:RAD) rose 14.8% to $9.45 amid speculation of activist interest.
    • ReShape Lifesciences Inc. (NASDAQ:RSLS) jumped 13.6% to $0.5534. ReShape Lifesciences was granted FDA 510(k) Premarket Notification for 'Gastrointestinal Boundary Identifier.'
    • Pearson plc (NYSE:PSO) gained 13.1% to $10.48 as the company backed its full-year profit guidance.
    • mCloud Technologies Corp. (NASDAQ:MCLD) gained 11.7% to $3.2963.
    • MAIA Biotechnology, Inc. (NASDAQ:MAIA) gained 11.4% to $6.46 after jumping 30% on Friday. The company agreed to initially offer 2.00 million shares to the public at a $5.00 per share.
    • Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) rose 11.3% to $1.8701 after dropping 10% on Friday. Tonix Pharmaceuticals recently announced a collaboration with the Kenya Medical Research Institute to plan, seek regulatory approval for and conduct a Phase 1 clinical study to develop TNX-801 as a vaccine to protect against monkeypox and smallpox.
    • Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) jumped 10.3% to $29.00 following Q2 results.
    • Golden Sun Education Group Limited (NASDAQ:GSUN) gained 9.8% to $33.00.
    • Roku, Inc. (NASDAQ:ROKU) gained 9.8% to $72.00. Morgan Stanley maintained Roku with an Underweight and lowered the price target from $80 to $55.
    • PerkinElmer, Inc. (NYSE:PKI) climbed 7.8% to $165.15 after the company reported better-than-expected Q2 financial results, issued Q3 guidance above estimates and raised its FY22 guidance above estimates. The company also announced it will divest its Applied, Food and Enterprise Services businesses to New Mountain Capital for total consideration of $2.45 billion in cash.
    • NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) shares rose 6.4% to $0.8441 after jumping over 51% on Friday. The U.S. Food and Drug Administration, last month, declined to issue an Emergency Use Authorization (EUA) for NRx Pharmaceuticals’ lead drug ZYESAMI (aviptadil) for subgroup of patients with critical COVID-19 at immediate risk of death from respiratory failure despite treatment with approved therapy, including remdesivir.
    • The Boeing Company (NYSE:BA) gained 6.3% to $169.29 following a report suggesting the FAA approved the company's inspection and modification plan to resume deliveries of the 787.
    • Li Auto Inc. (NASDAQ:LI) gained 6.2% to $34.89 after the company announced it delivered 10,422 Li ONEs in July 2022, up 21.3% year over year.
    • TOMI Environmental Solutions, Inc. (NASDAQ:TOMZ) rose 5.9% to $0.92 after dropping over 9% on Friday.
    • 36Kr Holdings Inc. (NASDAQ:KRKR) rose 5.3% to $1.21 after gaining more than 9% on Friday.
    • Lottery.com Inc. (NASDAQ:LTRY) rose 5% to $0.3097. Lottery.com shares tumbled around 64% on Friday after the company in an SEC filing said its board determined it does not have sufficient financial resources to fund operations.


    Losers

    • Otonomy, Inc. (NASDAQ:OTIC) shares tumbled 77.6% to $0.3202 after the company announced it will discontinue development of OTO-313 after the Phase 2 trial of OTO-313 in patients with tinnitus demonstrated no clinically meaningful improvement versus placebo for primary and secondary endpoints across all timepoints.
    • Kazia Therapeutics Limited (NASDAQ:KZIA) shares dipped 40.6% to $2.1514 after the company announced it's GBM AGILE pivotal study for paxalisib did not meet the pre-defined criteria for continuing to a second stage.
    • I-Mab (NASDAQ:IMAB) fell 35% to $6.78.
    • Xinyuan Real Estate Co., Ltd. (NYSE:XIN) fell 30% to $0.5011. Xinyuan Real Estate recently received letter from NYSE on listing compliance.
    • Zovio Inc (NASDAQ:ZVO) dropped 28.2% to $0.74 as the company reported a second-quarter FY22 sales decline of 25.7% year-on-year, to $51.38 million.
    • Powerbridge Technologies Co., Ltd. (NASDAQ:PBTS) declined 24.3% to $1.1050.
    • FiscalNote Holdings Inc. (NYSE:NOTE) fell 22.7% to $6.43. FiscalNote closed its earlier-announced agreement to acquire Aicel Technologies.
    • Missfresh Limited (NASDAQ:MF) dipped 21.1% to $0.0907. Missfresh recently announced adjustments to its business strategy, which will have an adverse impact on its financial performance.
    • Uxin Limited (NASDAQ:UXIN) fell 20% to $0.5642. Uxin recently posted Q4 earnings of $0.05 per share.
    • American Rebel Holdings, Inc. (NASDAQ:AREB) dropped 19.5% to $0.6085.
    • Tuniu Corporation (NASDAQ:TOUR) fell 18.5% to $0.9453.
    • Senti Biosciences, Inc. (NASDAQ:SNTI) fell 17.6% to $2.5799.
    • Mercurity Fintech Holding Inc. (NASDAQ:MFH) dipped 17% to $0.70.
    • Planet Green Holdings Corp. (NYSE:PLAG) dropped 16.5% to $0.81.
    • ThermoGenesis Holdings, Inc. (NASDAQ:THMO) fell 16.5% to $0.2251 after jumping 27% on Friday.
    • F45 Training Holdings Inc. (NYSE:FXLV) declined 16.5% to $1.6450.
    • JELD-WEN Holding, Inc. (NYSE:JELD) dipped 16.3% to $14.88 after the company posted downbeat Q2 earnings and lowered FY22 forecast.
    • Holley Inc. (NYSE:HLLY) dropped 16% to $6.72. Raymond James maintained Holley with an Outperform and lowered the price target from $14 to $10.
    • Q&K International Group Limited (NASDAQ:QK) fell 14.4% to $1.84.
    • Blue Water Vaccines, Inc. (NASDAQ:BWV) dropped 14.4% to $2.8660.
    • BiomX Inc. (NYSE:PHGE) fell 12.2% to $0.7878 after dropping 16% on Friday.
    • TuSimple Holdings Inc. (NASDAQ:TSP) dropped 9.5% to $9.01. The accident of an autonomously driven truck fitted with technology by TuSimple Holdings on April 6 has triggered concerns over risking safety on public roads, the Wall Street Journal reported.
    • Royal Caribbean Cruises Ltd. (NYSE:RCL) fell 9.2% to $35.15 after the company announced a private offering of senior convertible notes in an aggregate principal amount of up to $900 million.
    • Aerojet Rocketdyne Holdings, Inc. (NYSE:AJRD) dipped 8.5% to $39.92 after the company reported worse-than-expected Q2 EPS and sales results.
    • Innate Pharma S.A. (NASDAQ:IPHA) fell 7.5% to $2.84 after the company issued an update on AstraZeneca-sponsored INTERLINK-1 Phase 3 study. The company said the study did not meet pre-defined threshold for efficacy and will be discontinued.
    • iQIYI, Inc. (NASDAQ:IQ) dropped 7.2% to $3.5450. Shares of Chinese companies traded lower after July factory activity pulled back from June levels.
    Get the next $AEMD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AEMD
    $AJRD
    $AREB
    $BA

    CompanyDatePrice TargetRatingAnalyst
    Celsius Holdings Inc.
    $CELH
    2/27/2026$65.00Underperform → Buy
    BofA Securities
    GeoVax Labs Inc.
    $GOVX
    2/19/2026Buy → Hold
    D. Boral Capital
    Roku Inc.
    $ROKU
    2/13/2026$118.00Neutral → Buy
    Rosenblatt
    Li Auto Inc.
    $LI
    2/9/2026$14.00Neutral → Underweight
    Analyst
    Nanobiotix S.A.
    $NBTX
    2/6/2026Buy
    TD Cowen
    Roku Inc.
    $ROKU
    2/6/2026$105.00Perform → Outperform
    Oppenheimer
    Li Auto Inc.
    $LI
    1/23/2026$17.50Buy → Hold
    Jefferies
    Pearson Plc
    $PSO
    1/23/2026Reduce → Hold
    Kepler
    More analyst ratings

    $AEMD
    $AJRD
    $AREB
    $BA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Wilhelmsen Arne Alexander sold $243,570,580 worth of shares (771,607 units at $315.67) (SEC Form 4)

    4 - ROYAL CARIBBEAN CRUISES LTD (0000884887) (Issuer)

    2/27/26 5:01:55 PM ET
    $RCL
    Marine Transportation
    Consumer Discretionary

    EVP, Gov Ops, GPP & CS Shockey Jeffrey S covered exercise/tax liability with 4,444 shares, decreasing direct ownership by 16% to 23,294 units (SEC Form 4)

    4 - BOEING CO (0000012927) (Issuer)

    2/26/26 7:27:49 PM ET
    $BA
    Aerospace
    Industrials

    EVP and Chief HR Officer Amuluru Uma M sold $351,484 worth of shares (1,503 units at $233.78), decreasing direct ownership by 7% to 19,015 units (SEC Form 4)

    4 - BOEING CO (0000012927) (Issuer)

    2/26/26 7:21:47 PM ET
    $BA
    Aerospace
    Industrials

    $AEMD
    $AJRD
    $AREB
    $BA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Royal Caribbean Group announces completion of offering of $1.25 billion senior unsecured notes due 2033 and $1.25 billion senior unsecured notes due 2038

    MIAMI, Feb. 27, 2026 /PRNewswire/ -- Royal Caribbean Cruises Ltd. (NYSE:RCL) (the "Company") today announced that it has completed its registered public offering of $1.25 billion aggregate principal amount of 4.750% senior unsecured notes due 2033 (the "2033 Notes") and $1.25 billion aggregate principal amount of 5.250% senior unsecured notes due 2038 (the "2038 Notes" and, together with the 2033 Notes, the "Notes"). The 2033 Notes will mature on May 15, 2033 and the 2038 Notes will mature on February 27, 2038, unless earlier redeemed or repurchased. The Company intends to use t

    2/27/26 4:15:00 PM ET
    $RCL
    Marine Transportation
    Consumer Discretionary

    Li Auto Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026

    BEIJING, China, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Li Auto Inc. ("Li Auto" or the "Company") (NASDAQ:LI, HKEX: 2015)), a leader in China's new energy vehicle market, today announced that it will report its unaudited financial results for the fourth quarter and full year 2025 before the U.S. market opens on Thursday, March 12, 2026. The Company's management will hold an earnings conference call on Thursday, March 12, 2026, at 8:00 A.M. U.S. Eastern Time or 8:00 P.M. Beijing/Hong Kong Time on the same day. For participants who wish to join the call, please complete online registration using the link provided below prior to the scheduled call start time. Upon registration, participants will

    2/27/26 4:00:00 AM ET
    $LI
    Auto Manufacturing
    Industrials

    Pearson 2025 Preliminary Results (Unaudited)

    Confident in outlook, guiding to mid-single digit sales growth for 2026 and beyond. Strong financial position, with £350m share buyback well underway. LONDON, Feb. 27, 2026 /PRNewswire/ -- Financial Highlights£m2025vs 2024£m20252024Business performanceStatutory resultsSales3,577+4%1Sales3,5773,552Adjusted operating profit614+6%1Operating profit507541Operating cash flow571-14%2Profit for the period336435Free cash flow527+8%2Net cash generated from operations   731811Adjusted earnings per share   64.5p+4%2Basic earnings per share51.4p64.5pHighlightsUnderlying Group sales growth of

    2/27/26 2:06:00 AM ET
    $PSO
    Books
    Consumer Discretionary

    $AEMD
    $AJRD
    $AREB
    $BA
    SEC Filings

    View All

    Royal Caribbean Cruises Ltd. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - ROYAL CARIBBEAN CRUISES LTD (0000884887) (Filer)

    2/27/26 4:30:45 PM ET
    $RCL
    Marine Transportation
    Consumer Discretionary

    SEC Form 6-K filed by Li Auto Inc.

    6-K - Li Auto Inc. (0001791706) (Filer)

    2/27/26 4:02:05 PM ET
    $LI
    Auto Manufacturing
    Industrials

    SEC Form 6-K filed by Li Auto Inc.

    6-K - Li Auto Inc. (0001791706) (Filer)

    2/27/26 4:01:46 PM ET
    $LI
    Auto Manufacturing
    Industrials

    $AEMD
    $AJRD
    $AREB
    $BA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Smith Stan bought $9,959 worth of shares (2,700 units at $3.69) and received a gift of 20,000 shares (SEC Form 4)

    4 - MAIA Biotechnology, Inc. (0001878313) (Issuer)

    1/12/26 8:44:30 AM ET
    $MAIA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Thompson Tommy G bought $14,031 worth of shares (8,400 units at $1.67), increasing direct ownership by 57% to 23,179 units (SEC Form 4)

    4 - TherapeuticsMD, Inc. (0000025743) (Issuer)

    12/29/25 4:23:31 PM ET
    $TXMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Smith Stan bought $69,999 worth of shares (57,189 units at $1.22) (SEC Form 4)

    4 - MAIA Biotechnology, Inc. (0001878313) (Issuer)

    12/23/25 8:18:50 AM ET
    $MAIA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEMD
    $AJRD
    $AREB
    $BA
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for BIJUVA issued to THERAPEUTICSMD INC

    Submission status for THERAPEUTICSMD INC's drug BIJUVA (SUPPL-6) with active ingredient ESTRADIOL; PROGESTERONE has changed to 'Approval' on 12/28/2021. Application Category: NDA, Application Number: 210132, Application Classification: Efficacy

    12/29/21 7:23:57 AM ET
    $TXMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for IMVEXXY issued to THERAPEUTICSMD INC

    Submission status for THERAPEUTICSMD INC's drug IMVEXXY (SUPPL-2) with active ingredient ESTRADIOL has changed to 'Approval' on 11/16/2021. Application Category: NDA, Application Number: 208564, Application Classification: Labeling

    11/17/21 4:38:32 AM ET
    $TXMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for BIJUVA issued to THERAPEUTICSMD INC

    Submission status for THERAPEUTICSMD INC's drug BIJUVA (SUPPL-3) with active ingredient ESTRADIOL; PROGESTERONE has changed to 'Approval' on 06/22/2021. Application Category: NDA, Application Number: 210132, Application Classification: Labeling

    6/24/21 5:13:50 AM ET
    $TXMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEMD
    $AJRD
    $AREB
    $BA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Celsius upgraded by BofA Securities with a new price target

    BofA Securities upgraded Celsius from Underperform to Buy and set a new price target of $65.00

    2/27/26 8:20:43 AM ET
    $CELH
    Beverages (Production/Distribution)
    Consumer Staples

    GeoVax Labs downgraded by D. Boral Capital

    D. Boral Capital downgraded GeoVax Labs from Buy to Hold

    2/19/26 8:44:06 AM ET
    $GOVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Roku upgraded by Rosenblatt with a new price target

    Rosenblatt upgraded Roku from Neutral to Buy and set a new price target of $118.00

    2/13/26 8:26:09 AM ET
    $ROKU
    Cable & Other Pay Television Services
    Telecommunications

    $AEMD
    $AJRD
    $AREB
    $BA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Tuniu Corporation

    SC 13D/A - Tuniu Corp (0001597095) (Subject)

    12/6/24 6:30:27 AM ET
    $TOUR
    Transportation Services
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Senti Biosciences Inc.

    SC 13D/A - Senti Biosciences, Inc. (0001854270) (Subject)

    12/4/24 7:08:03 PM ET
    $SNTI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13D/A filed by iQIYI Inc.

    SC 13D/A - iQIYI, Inc. (0001722608) (Subject)

    12/4/24 8:11:53 AM ET
    $IQ
    Consumer Electronics/Video Chains
    Consumer Discretionary

    $AEMD
    $AJRD
    $AREB
    $BA
    Leadership Updates

    Live Leadership Updates

    View All

    Pearson 2025 Preliminary Results (Unaudited)

    Confident in outlook, guiding to mid-single digit sales growth for 2026 and beyond. Strong financial position, with £350m share buyback well underway. LONDON, Feb. 27, 2026 /PRNewswire/ -- Financial Highlights£m2025vs 2024£m20252024Business performanceStatutory resultsSales3,577+4%1Sales3,5773,552Adjusted operating profit614+6%1Operating profit507541Operating cash flow571-14%2Profit for the period336435Free cash flow527+8%2Net cash generated from operations   731811Adjusted earnings per share   64.5p+4%2Basic earnings per share51.4p64.5pHighlightsUnderlying Group sales growth of

    2/27/26 2:06:00 AM ET
    $PSO
    Books
    Consumer Discretionary

    Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026

    Aethlon invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation on the Emerging Growth Conference.SAN DIEGO, Feb. 23, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (the Company or Aethlon) (NASDAQ:AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, is pleased to announce that it has been invited to present on the Emerging Growth Conference on February 25, 2026 at 12:30-1:00 PM ET. This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company's CEO and CFO, Jim Frakes in

    2/23/26 8:01:00 AM ET
    $AEMD
    Medical/Dental Instruments
    Health Care

    Royal Caribbean Group Appoints Christopher J. Wiernicki to Board of Directors

    MIAMI, Feb. 17, 2026 /PRNewswire/ -- Royal Caribbean Group (NYSE:RCL) today announced the appointment of Christopher J. Wiernicki, former Chairman & CEO, American Bureau of Shipping (ABS), to its Board of Directors, effective immediately. Wiernicki brings more than four decades of commercial, government and international experience in marine and offshore design, along with operations, infrastructure and safety management, ports and bunkering, digitalization, cyber security, and clean energy transition expertise.During his fourteen-year tenure at the helm of ABS, a global leader

    2/17/26 8:27:00 AM ET
    $RCL
    Marine Transportation
    Consumer Discretionary

    $AEMD
    $AJRD
    $AREB
    $BA
    Financials

    Live finance-specific insights

    View All

    Li Auto Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026

    BEIJING, China, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Li Auto Inc. ("Li Auto" or the "Company") (NASDAQ:LI, HKEX: 2015)), a leader in China's new energy vehicle market, today announced that it will report its unaudited financial results for the fourth quarter and full year 2025 before the U.S. market opens on Thursday, March 12, 2026. The Company's management will hold an earnings conference call on Thursday, March 12, 2026, at 8:00 A.M. U.S. Eastern Time or 8:00 P.M. Beijing/Hong Kong Time on the same day. For participants who wish to join the call, please complete online registration using the link provided below prior to the scheduled call start time. Upon registration, participants will

    2/27/26 4:00:00 AM ET
    $LI
    Auto Manufacturing
    Industrials

    Celsius Holdings Reports Full-Year 2025 and Fourth Quarter Financial Results

    Record annual revenue of $2.5 billion reflects scale and disciplined growth in fast-growing energy category Strategic energy leadership and portfolio integration within PepsiCo system positions company for sustainable growth Celsius Holdings' portfolio contributed 33% of the zero-sugar l U.S. energy category's $3.3 billion growth in 20251 Celsius Holdings, Inc. (NASDAQ:CELH) ("Celsius Holdings" or "the company") today reported fourth quarter and full-year 2025 financial results. Summary of Fourth Quarter and Full-Year 2025 Financial Results Summary Financials 4Q 2025   4Q 2024   Change FY 2025 FY 2024 Change   (Milli

    2/26/26 6:00:00 AM ET
    $CELH
    Beverages (Production/Distribution)
    Consumer Staples

    iQIYI Announces Fourth Quarter and Fiscal Year 2025 Financial Results

    BEIJING, China, Feb. 26, 2026 (GLOBE NEWSWIRE) -- iQIYI, Inc. (NASDAQ:IQ) ("iQIYI" or the "Company"), a leading provider of online entertainment video services in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025.          Fourth Quarter 2025 Highlights Total revenues were RMB6.79 billion (US$971.6 million1), increasing 3% year over year.Operating income was RMB55.4 million (US$7.9 million) and operating income margin was 1%, compared to operating income of RMB285.4 million and operating income margin of 4% in the same period in 2024.Non-GAAP operating income2 was RMB143.5 million (US$20.5 million) and non-GAAP operating

    2/26/26 4:00:00 AM ET
    $IQ
    Consumer Electronics/Video Chains
    Consumer Discretionary